Keywords
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Azithromycin (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Azithromycin (pharmacokinetics) < Azithromycin (pharmacology) < Azithromycin (supply & distribution)  Facettes :

List of bibliographic references indexed by Azithromycin (pharmacology)

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000014 (2021) Julio Echarte-Morales [Espagne] ; Carlos Minguito-Carazo [Espagne] ; Samuel Del Castillo-García [Espagne] ; Javier Borrego-Rodríguez [Espagne] ; Miguel Rodríguez-Santamarta [Espagne] ; Enrique Sánchez-Mu Oz [Espagne] ; Rubén Bergel-García [Espagne] ; Clea González-Maniega [Espagne] ; Silvia Prieto-González [Espagne] ; Paula Menéndez-Suarez [Espagne] ; Elena Tundidor-Sanz [Espagne] ; Tomás Benito-González [Espagne] ; Felipe Fernández-Vázquez [Espagne]Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
000193 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Hervé Chaudet [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
000355 (2021) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
000604 (2021) Guillaume Hache [France] ; Jean Marc Rolain [France] ; Philippe Gautret [France] ; Jean-Claude Deharo [France] ; Philippe Brouqui [France] ; Didier Raoult [France] ; Stéphane Honoré [France]Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.
000693 (2021) Cosmin Andrei Cismaru [Roumanie] ; Gabriel Laurentiu Cismaru [Roumanie] ; Fazel Seyed Nabavi [Iran] ; Mohammad Seyed Nabavi [Iran] ; Ioana Berindan-Neagoe [Roumanie]COVID-19 and antimalarials. Have we been doing it wrong all along?
000699 (2021) Mark Szendrey [Canada] ; Jun Guo [Canada] ; Wentao Li [Canada] ; Tonghua Yang [Canada] ; Shetuan Zhang [Canada]COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels.
000714 (2021) Daniel Echeverría-Esnal [Espagne] ; Clara Martin-Ontiyuelo [Espagne] ; María Eugenia Navarrete-Rouco [Espagne] ; Marta De-Antonio Cusc [Espagne] ; Olivia Ferrández [Espagne] ; Juan Pablo Horcajada [Espagne] ; Santiago Grau [Espagne]Azithromycin in the treatment of COVID-19: a review.
000733 (2021) Sherif Sultan [Irlande (pays)] ; Yogesh Acharya [Irlande (pays)]Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned.
000765 (2021) Eric Duverger [France] ; Guillaume Herlem [France] ; Fabien Picaud [France]A potential solution to avoid overdose of mixed drugs in the event of Covid-19: Nanomedicine at the heart of the Covid-19 pandemic.
000A33 (2020) Nadine Shehab [Géorgie (pays)] ; Maribeth Lovegrove [Géorgie (pays)] ; Daniel S. Budnitz [Géorgie (pays)]US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
000B70 (2020) Jun Wu [États-Unis]Tackle the free radicals damage in COVID-19.
000B83 (2020) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000B84 (2020) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000D44 (2020) Julian D. Machiels [Pays-Bas] ; Chantal P. Bleeker-Rovers [Pays-Bas] ; Rob Ter Heine [Pays-Bas] ; Janette Rahamat-Langendoen [Pays-Bas] ; Quirijn De Mast [Pays-Bas] ; Jaap Ten Oever [Pays-Bas] ; Teun Bousema [Pays-Bas] ; Reinout Van Crevel [Pays-Bas] ; Heiman Fl Wertheim [Pays-Bas]Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
001024 (2020) Tarek Kashour [Arabie saoudite] ; Imad M. Tleyjeh [Arabie saoudite]It is time to drop hydroxychloroquine from our COVID-19 armamentarium.
001038 (2020) J M Scherrmann [France]Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy.
001071 (2020) Julien Andreani [France] ; Marion Le Bideau [France] ; Isabelle Duflot [France] ; Priscilla Jardot [France] ; Clara Rolland [France] ; Manon Boxberger [France] ; Nathalie Wurtz [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Didier Raoult [France]In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect.
001073 (2020) Helyson Lucas Bezerra Braz [Brésil] ; João Alison De Moraes Silveira [Brésil] ; Aline Diogo Marinho [Brésil] ; Maria Elisabete Amaral De Moraes [Brésil] ; Manoel Odorico De Moraes Filho [Brésil] ; Helena Serra Azul Monteiro [Brésil] ; Roberta Jeane Bezerra Jorge [Brésil]In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
001149 (2020) Pauline Maisonnasse [France] ; Jérémie Guedj [France] ; Vanessa Contreras [France] ; Sylvie Behillil [France] ; Caroline Solas [France] ; Romain Marlin [France] ; Thibaut Naninck [France] ; Andres Pizzorno [France] ; Julien Lemaitre [France] ; Antonio Gonçalves [France] ; Nidhal Kahlaoui [France] ; Olivier Terrier [France] ; Raphael Ho Tsong Fang [France] ; Vincent Enouf [France] ; Nathalie Dereuddre-Bosquet [France] ; Angela Brisebarre [France] ; Franck Touret [France] ; Catherine Chapon [France] ; Bruno Hoen [France] ; Bruno Lina [France] ; Manuel Rosa Calatrava [France] ; Sylvie Van Der Werf [France] ; Xavier De Lamballerie [France] ; Roger Le Grand [France]Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
001269 (2020) John L. Sapp [Canada] ; Wael Alqarawi [Canada] ; Ciorsti J. Macintyre [Canada] ; Rafik Tadros [Canada] ; Christian Steinberg [Canada] ; Jason D. Roberts [Canada] ; Zachary Laksman [Canada] ; Jeff S. Healey [Canada] ; Andrew D. Krahn [Canada]Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society.
001319 (2020) Hartmut Derendorf [États-Unis]Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Azithromycin (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Azithromycin (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Azithromycin (pharmacology)
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021